]>
IRCT20180103038199N4 IRCT 2021-04-24 Mashhad University of Medical Sciences Effect of Basil on outpatients with COVID-19 Evaluation of the effectiveness of complementary therapy with Basil (Ocimum basilicum) capsule on the clinical symptoms of outpatients with COVID-19 2021-12-31 anticipated 140 Complete https://irct.ir/trial/54965 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: The volume of each block will be 4. Then write a list of blocks and assign numbers to them, for example (AABB (1) - BBAA (2) - BABA (3) - BAAB (4)) which according to the sample size of 140 people, we have 35 blocks. Then, random numbers between one and 35 are selected according to the Randomaize.com randomization site, and finally, the treatment allocation list is determined based on random numbers, Blinding description: Due to the use of a placebo similar to interventional therapy, the physician associated with the participants and participants will not be informed of the assigned treatment and also the analyst will be unaware of the treatment assigned to the two groups. Finally, after analyzing the data, the researcher who prepared the packages reveals codes A and B. 2-3 COVID-19 disease. Intervention 1: Control group: Receive common treatments based on the ministry of health protocol + placebo capsules (Avicell) made in Mashhad school of Persian and complementary medicine twice a day for 10 days. Intervention 2: Intervention group: Receive common treatments based on the ministry of health protocol + capsules containing 300 mg of basil extract made in Mashhad school of Persian and complementary medicine 2 times a day for 10 days. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no more information
public Dr Vahid Reza Askari
Faculty of Medicine, Azadi sq, Mashhad
Mashhad Iran (Islamic Republic of) 9177948564 +98 915 371 9688 askariv@mums.ac.ir Mashhad University of Medical Sciences scientific Dr Vahid Reza Askari
Faculty of Medicine, Azadi sq, Mashhad
Mashhad Iran (Islamic Republic of) 9177948564 +98 915 371 9688 askariv@mums.ac.ir Mashhad University of Medical Sciences Iran (Islamic Republic of) Outpatients with COVID-19 Confirmed with RT-PCR SPO2 more than 90% Age between 18 to 60 years old 18 years 60 years Both Pregnant women Breastfeeding women U07.1 COVID-19 Placebo Treatment - Drugs Control group: Receive common treatments based on the ministry of health protocol + placebo capsules (Avicell) made in Mashhad school of Persian and complementary medicine twice a day for 10 days Intervention group: Receive common treatments based on the ministry of health protocol + capsules containing 300 mg of basil extract made in Mashhad school of Persian and complementary medicine 2 times a day for 10 days Time to recover from illness based on questionnaire. Timepoint: before intervention and 3, 7 and 14 days after beginning the intervention. Method of measurement: questionnaire. Normalization of CRP and lymphopenia. Timepoint: before the intervention and 14 days after The beginning the intervention. Method of measurement: laboratory. Mashhad University of Medical Sciences Approved 2021-01-30 Ethics committee of Mashhad University of Medical Sciences Deputy of Research and Technology of the University, Qurashi Building, Next to Hoveyzeh Cinema, University Street Mashhad Razavi Khorasan Iran (Islamic Republic of)